Improvement in physicochemical properties of nevirapine co-crystals

International Journal of Pharmacy and Technology

Volumn 4, Issue 4, 2012, Pages 4831-4842

  Gujar, P P ^a   Kokil, A A ^a   Karekar, P S ^a   Gurav, Y A ^a   Yadav, A V ^a  

^a Gourishankar Institute of Pharmaceutical Education Reseach   (India)

Author keywords

Cocrystallization; Dissolution behavior; Micromeritic properties; Nevirapine

Indexed keywords

BENZOIC ACID; NEVIRAPINE; OXALIC ACID;

ARTICLE; CRYSTAL; CRYSTALLIZATION; DRUG SOLUBILITY; HYDROGEN BOND; MELTING POINT; PHYSICAL CHEMISTRY;

EID: 84874405048     PISSN: None     EISSN: 0975766X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. C Li; C Li; Y Lea; JF Chenb. International Journal of Pharmaceutics, 2011, Vol 404, pp 257-263.
2. CA Lipinski. Curr. Drug Discov., 2001. pp17-19.
3. CA Lipinski. Am. Pharm. Rev., 2002, Vol 5, pp 82-85.
4. E.L. Paul, H.H. Tung, M. Midler, Organic crystallization processes, Powder Technol. 2005, vol 150, pp133-43.
5. S.R. Byrn, R.R. Pfeiffer, J.G. Stowell, Solid-State chemistry of drugs, West Lafayette; SSCI: 1999.
6. H. Brittain (Eds), Polymorphism in pharmaceutical solids, Vol. 95, New York; Marcel Dekker; 1999.
7. A. Llinas, J.M. Goodman, Polymorph control: past, present and future, Drug Discovery Today. 2008, Vol 13, pp 198-210.
8. A. V. Yadav, A.S. Shete, A.P. Dabke, P.V. Kulkarni, S.S. Sakhare, Co-crystals: A novel approach to modify physicochemical properties of active ingredients, Indian J. Pharm. Sci. 2009 Vol 71, pp 359-370.
9. RL Carrier; LA Miller; I Ahmed. Journal of Controlled Release, 2007, Vol 123, pp 78-99.
10. WL Chiou; S Riegelman. J. Pharm. Sci. 1971, Vol 60, 9, pp 1281-1302.
11. BC Hancock; G Zografi. J Pharm Sci., 1997, Vol 86, pp 1-12.
12. H Schott; LC Kwan; S Feldman. J. Pharm. Sci,. 1982, Vol 71, 9, pp 1038-1045.
13. S Gibaud; A Bonneville; A Astier. International Journal of Pharmaceutics, 2002, Vol 242, pp 197-201.
14. NA Ochekpe; PO Olorunfemi; NC Ngwuluka. Tropical Journal of Pharmaceutical Research. 2009, Vol 8, 3, pp 275-287.
15. S.L. Childs, L.J. Chyall, J.T. Dunlap, V.N. Smolenskaya, B.C. Stahly, G.P. Stahly, Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic and fumaric acids, J. Am. Chem. Soc. 2004, Vol 126, pp 13335-13342.
16. J.F. Remenar, S.L. Morissette, M.L. Peterson, B. Moulton, J.M. MacPhee, H.R. Guzman, O. Almarsson, Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids, J. Am. Chem. Soc. 2003, Vol 125, pp 8456-8457.
17. D.P. McNamara, S.L. Childs, J. Giordano, A. Iarriccio, J. Cassidy, M.S. Shet, R. Mannion, E. O'Donnell, A. Park, Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API, Pharm. Res. 2006, Vol 231, pp 888-1897.
18. A.V. Trask, W.D.S. Motherwell, W. Jones, Pharmaceutical cocrystallization: Engineering a remedy for caffeine hydration, Cryst. Growth Des. 2005, Vol 5, pp 1013-1021.
19. A.V. Trask, W.D. Motherwell, W. Jones, Physical stability enhancement of theophylline via cocrystallization, Int. J. Pharm. 2006, Vol 320, pp 114-123.
20. Neeraj Kaul, Himani Agrawal, A.R. Paradkar, K.R. Mahadik. HPTLC method for determination of nevirapine in pharmaceutical dosage form. Talanta 2004, Vol 62, pp 843-852.
21. N. Schultheiss, A. Newman, Pharmaceutical co-crystals and their physicochemical properties, Cryst Growth Des. 2009, Vol 9, pp 2950-2967.
22. C.V.S. Subrahmanyam, Micromeritics, Textbook of Physical Pharmaceutics, second ed., Vallabh Prakashan, Delhi, 2000, pp 221-227.
23. Y. Kawashima, M. Imai, H. Takeuchi, H. Yamamoto, K. Kamiya, T. Hino, Improved flowability and compactibility of spherically agglomerated crystals of ascorbic acid for direct tableting designed by spherical crystallization process, Powder Technol. 2003, Vol 130, pp 283-289.
24. Yadav VB, Yadav AV Comparative Tabletting behavior of Carbamazepine granules with spherical agglomerated crystals prepared by spherical crystallization technique. International Journal of Chem Tech Research. 2009, pp 18-25.
25. P.J. Sinko, Micromeritics, Martins Physical Pharmacy and Pharmaceutical Sciences, fifth ed., Lippincott Williams and Wilkins, 2007, pp. 557.
26. G. Buckton, Solid state properties, in: M.E. Aulton (Ed), Pharmaceutics: The science of dosage form, Churchill Livingstone, 1998.
27. A. Nokhodchi, M. Maghsoodi, D. Hassanzadeh, An improvement of physicomechanical properties of carbamazepine crystals, Iranian J. Pharm. Res. 2007, 6, pp 83-93.
28. H.A. Garekani, F. Sadeghi, A. Badiee, S.A. Mostafa, A.R. Rajabi-Siahboomi, Crystal habit modifications of ibuprofen and their physicomechanical characteristics, Drug Dev. Ind. Pharm. 2001, 27, pp 803-809.
29. A.V. Yadav, A.P. Dabke, A.S. Shete, Crystal engineering to improve physicochemical properties of mefloquine hydrochloride, Drug Dev. Ind. Pharm. 2010, 36, pp 1036-1045.